Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 1

Cardiovascular morbidity and the use of inhaled bronchodilators

Authors Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas Anthonisen

Published Date March 2008 Volume 2008:3(1) Pages 163—169

DOI http://dx.doi.org/10.2147/COPD.S1516

Published 18 March 2008

Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas Anthonisen

Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

Abstract: We used the Manitoba Health database to examine the relationship between use of inhaled respiratory drugs in people with chronic obstructive respiratory diseases and cardiovascular hospitalizations from 1996 through 2000. The drugs examined were beta agonists [BA], ipratropium bromide IB, and inhaled steroids (ICS). End points were first hospitalizations for supraventricular tachycardia, myocardial infarction, heart failure or stroke. A nested case control analysis was employed comparing people with and without cardiovascular events. Cases and controls were matched for gender and age, and conditional logistic regression was used in multivariate analysis considering other respiratory drugs, respiratory diagnosis and visit frequency, non-respiratory, non-cardiac comorbidities, and receipt of drugs for cardiovascular disease. In univariate analyses, BA, IB and ICS were all associated with hospitalizations for cardiovascular disease, but in multivariate analyses ICS did not increase risk while both BA and IB did. There were interactions between respiratory and cardiac drugs receipt in that bronchodilator associated risks were higher in people not taking cardiac drugs; this was especially true for stroke. There were strong interactions with specific cardiac drugs; for example, both BA and IB substantially increased the risk of supraventricular tachycardia in patients not anti-arryhthmic agents, but not in the presence of such agents. We conclude that bronchodilator therapy for chronic obstructive diseases is associated with increased cardiovascular risk, especially in patients without previous cardiovascular diagnoses, and that this is unlikely due to the severity of the respiratory disease, since risk was not increased with ICS.

Keywords: bronchodilator therapy, inhaled corticosteroids, nested case control study

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Nanotechnology-based approaches in anticancer research

Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA

International Journal of Nanomedicine 2012, 7:4391-4408

Published Date: 9 August 2012

Self-assembled mPEG–PCL-g–PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro

Shi S, Zhu XC, Guo QF, Wang YJ, Zuo T, Luo F, Qian ZY

International Journal of Nanomedicine 2012, 7:1749-1759

Published Date: 30 March 2012

Factors associated with good self-rated health and quality of life in subjects with self-reported COPD

Arne M, Lundin F, Boman G, Janson C, Janson S, Emtner M

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:511-519

Published Date: 7 October 2011

Biodiversity: crises past and present, and future challenges

Lane DJW

Research and Reports in Biodiversity Studies 2011, 1:1-2

Published Date: 22 June 2011

Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs

Rao S, Song Y, Peddie F, Evans AM

International Journal of Nanomedicine 2011, 6:1245-1251

Published Date: 20 June 2011

Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians

Gregory D Salinas, James C Williamson, Ravi Kalhan, et al

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:171-179

Published Date: 28 February 2011

Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction

Barbara P Yawn, Douglas W Mapel, David M Mannino, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:1-10

Published Date: 17 December 2009